Sponsor Dossier
MedTAS
Sponsor Dossier for MedTAS. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ALIMETREX
- Brand: APO-VORICONAZOLE
- Brand: ARIMIZOLE
- Brand: CANCIGIN
- Brand: CASPODAS
- Brand: CASPOFUNGIN JUNO
- Brand: CEFTRIAXON
- Brand: CEFTRIX
- Device (sponsor): Multi-purpose saline solution
- Device (sponsor): Lubricant, eye
- Device (sponsor): Lubricant, eye
About
MedTAS is an Australian Private Company with ABN 72644270860, registered in NSW. The entity is active and registered for GST.
Portfolio
MedTAS holds 53 brands on the ARTG, of which 4 are indexable brands that have cleared the SEO quality gate. Three brands have Product Information on file. One brand has at least one PBS-listed item. The portfolio includes no brands with PBAC outcomes or AusPARs on record.
Therapeutic focus —
Infectious Disease: 16 brands — Oncology: 9 brands — Gastroenterology: 7 brands — Pain & Anaesthesia: 6 brands — Cardiology: 5 brands — Neurology: 3 brands — Endocrinology: 3 brands — Reproductive Health: 1 brand — Musculoskeletal: 1 brand — Respiratory: 1 brand — Immunology: 1 brand
PBS footprint
One brand in the MedTAS portfolio holds at least one PBS-listed item. The latest PBS schedule date their portfolio touched is 2026-05-01.